Discover how early detection and innovative treatments are transforming the fight against colorectal cancer this Awareness Month.
PHILADELPHIA — The investigational drug verekitug improved sinonasal symptoms, reduced nasal polyp size, and reduced the need for nasal polyp surgery in people with chronic rhinosinusitis with nasal ...
Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had significantly decreased nasal polyp size at week 24, according to a poster ...
Colorectal cancer screening guidelines now recommend beginning routine colonoscopies at age 45 for average-risk adults.
Michigan plays Howard in the first round of March Madness, here's how to watch. BYU will meet Texas in the first round of the ...
The Punch on MSN
Colorectal cancer cases rising among young people – Experts
Medical experts have raised concerns over the increasing incidence of colorectal cancer among young Nigerians, warning that changing lifestyles and late diagnosis are driving the troubling trend.They ...
- Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p in new analysis with adjustment for concomitant rescue therapy use- -Secondary endpoints also provided strong ...
(MENAFN- GlobeNewsWire - Nasdaq) – Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p 0.0001) in new analysis with adjustment for concomitant rescue therapy use – – ...
March 23, 2026 Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical sta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results